Granite Point Capital Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,900
Closed -$727K 69
2022
Q4
$727K Buy
+25,900
New +$742K 0.46% 41
2021
Q4
Sell
-23,000
Closed -$713K 135
2021
Q3
$713K Buy
+23,000
New +$552K 0.05% 108
2019
Q4
Sell
-50,000
Closed -$360K 92
2019
Q3
$360K Hold
50,000
0.06% 66
2019
Q2
$398K Buy
+50,000
New +$592K 0.03% 81
2018
Q1
Sell
-100,000
Closed -$1.23M 117
2017
Q4
$1.23M Buy
100,000
+50,000
+100% +$705K 0.12% 48
2017
Q3
$890K Buy
+50,000
New +$1.03M 0.19% 60
2015
Q4
Sell
-87,828
Closed -$1.4M 89
2015
Q3
$1.4M Sell
87,828
-5,158
-6% -$101K 0.96% 24
2015
Q2
$1.81M Buy
+92,986
New +$1.73M 0.53% 26

Other funds holding EVH

Granite Point Capital Management's EVH Position: Q1 2023 in Review

Granite Point Capital Management sold out of Evolent Health (EVH) in Q1 2023, closing a stake of 25,900 shares — an estimated $727K sold.

Granite Point Capital Management first reported a position in EVH in Q2 2015 and held it in 8 quarters. The position peaked at $1.81M in Q2 2015. 240 funds tracked by Wall St. Rank hold EVH as of Q1 2023.

  • Granite Point Capital Management reported no remaining Evolent Health position as of Q1 2023 after selling out during the quarter.
  • Granite Point Capital Management sold 25,900 Evolent Health shares in Q1 2023, an estimated $727K.
  • Granite Point Capital Management first reported a position in Evolent Health in Q2 2015 and held it in 8 quarters.
  • Granite Point Capital Management's Evolent Health position peaked at $1.81M in Q2 2015.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q1 2023.

Based on Granite Point Capital Management's 13F filing for Q1 2023, filed 11 May 2023.